On September 22, recognized as World CML Day, Almazov Centre held an online training for patients and their families as well as for doctors of various specialties.
The training brought together about 60 people participants not only from Saint Petersburg but also from other regions of Russia. Elza Lomaia, Leading Researcher of Oncology and Hematology Research Department opened the event with a welcome speech and spoke about chronic myeloid leukemia, diagnosis, treatment and possible recovery. Dr. Lomaia tried to deliver the information in simple terms, paying special attention to the topics “Stop therapy” and “COVID-19 and CML”.
Darina Zammoeva, hematologist at the Department of Chemotherapy and Bone Marrow Transplantation No. 2, gave a presentation on the history of bone marrow transplantation (BMT) as a treatment option, on the advanced possibilities of allogeneic transplantation as well as haplo-BMT.
Closing the medical part of the training, Dr. Lomaia announced clinical trials to be conducted in 2021.
“Participation in clinical trials for patients implies not only new TKIs, but also new opportunities,” concluded Elza Lomaia.
It should be noted that trainings for CML patients in St. Petersburg are traditionally held in a friendly atmosphere and are equally interesting for newly ill patients and for those with advanced illness.